Subtype
Genitourinary System Carcinoma
CI-CAN-00000925Explore in graph →
1,498 active trials44 approved drugs143 evidence items
- NCIt
- C164141
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000925Explore in graph →
Clinical trials
4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (758)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06428708 | [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma | unknown | Early Phase 1 | 30 | Western UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05558956 | Total Body PET-CT Imaging of Prostate Cancer Using Illuccix | unknown | Early Phase 1 | 100 | BAMF HealthOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05638256 |
| 68Ga-labeled NY104 PET Imaging in Patients |
| unknown |
| Early Phase 1 |
| 10 |
| Affiliated Hospital of Jiangnan UniversityOTHER |
| 1 |
| Dec 6, 2022 |
| clinicaltrials |
| NCT03692663 | Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer | unknown | Early Phase 1 | 9 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 1, 2022 | clinicaltrials |
| NCT05087264 | Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical Cancer | unknown | Early Phase 1 | 86 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01) | unknown | Early Phase 1 | 28 | Shanghai Fengxian District Central HospitalOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT04225910 | Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer | unknown | Early Phase 1 | 20 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT03960788 | Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer | unknown | Early Phase 1 | 50 | University of CincinnatiOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT03692637 | Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer | unknown | Early Phase 1 | 30 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Jun 25, 2024source: clinicaltrials